ozcrop azoxycypro wg fungicide
oz crop pty ltd - azoxystrobin; cyproconazole - water dispersible granule - azoxystrobin pyrimidine active 600.0 g/kg; cyproconazole triazole active 240.0 g/kg - fungicide
ac consort 400 herbicide
axichem pty ltd - carfentrazone-ethyl; n-methyl-2-pyrrolidone; liquid hydrocarbon - emulsifiable concentrate - carfentrazone-ethyl ungrouped active 400.0 g/l; n-methyl-2-pyrrolidone solvent other 100.0 g/l; liquid hydrocarbon solvent other 452.0 g/l - herbicide
ac pacer 550 ec fungicide
axichem pty ltd - propiconazole; liquid hydrocarbon - emulsifiable concentrate - propiconazole triazole active 550.0 g/l; liquid hydrocarbon solvent other 371.0 g/l - fungicide
pharmacor rasagiline rasagiline (as mesilate) 1 mg tablet bottle pack
pharmacor pty ltd - rasagiline mesilate, quantity: 1.56 mg (equivalent: rasagiline, qty 1 mg) - tablet, uncoated - excipient ingredients: purified talc; citric acid monohydrate; pregelatinised maize starch; colloidal anhydrous silica; microcrystalline cellulose; maize starch; stearic acid - pharmacor rasagiline is indicated for the symptomatic treatment of idiopathic parkinson?s disease (pd) as monotherapy and as adjunct therapy to dopamine agonists or to levodopa.
akm rasagiline rasagiline (as mesilate) 1 mg tablet blister pack
pharmacor pty ltd - rasagiline mesilate, quantity: 1.56 mg (equivalent: rasagiline, qty 1 mg) - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; pregelatinised maize starch; stearic acid; purified talc; citric acid monohydrate; maize starch - akm rasagiline is indicated for the symptomatic treatment of idiopathic parkinson?s disease (pd) as monotherapy and as adjunct therapy to dopamine agonists or to levodopa.
akm rasagiline rasagiline (as mesilate) 1 mg tablet bottle pack
pharmacor pty ltd - rasagiline mesilate, quantity: 1.56 mg (equivalent: rasagiline, qty 1 mg) - tablet, uncoated - excipient ingredients: purified talc; colloidal anhydrous silica; pregelatinised maize starch; maize starch; stearic acid; microcrystalline cellulose; citric acid monohydrate - akm rasagiline is indicated for the symptomatic treatment of idiopathic parkinson?s disease (pd) as monotherapy and as adjunct therapy to dopamine agonists or to levodopa.
pharmacor rasagiline rasagiline (as mesilate) 1 mg tablet blister pack
pharmacor pty ltd - rasagiline mesilate, quantity: 1.56 mg (equivalent: rasagiline, qty 1 mg) - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; stearic acid; citric acid monohydrate; purified talc; maize starch; microcrystalline cellulose; pregelatinised maize starch - pharmacor rasagiline is indicated for the symptomatic treatment of idiopathic parkinson?s disease (pd) as monotherapy and as adjunct therapy to dopamine agonists or to levodopa.
duodart
glaxo smith kline (israel) ltd - dutasteride; tamsulosin hydrochloride - capsules - dutasteride 0.5 mg; tamsulosin hydrochloride 0.4 mg - tamsulosin - treatment of moderate to severe symptoms of benign prostatic hyperplasia (bph). reduction in the risk of acute urinary retention (aur) and surgery in patients with moderate to severe symptoms of bph.
duodart
glaxo smith kline (israel) ltd - dutasteride; tamsulosin hydrochloride - capsules - dutasteride 0.5 mg; tamsulosin hydrochloride 0.4 mg - tamsulosin - treatment of moderate to severe symptoms of benign prostatic hyperplasia (bph). reduction in the risk of acute urinary retention (aur) and surgery in patients with moderate to severe symptoms of bph.
duodart
glaxo smith kline (israel) ltd - dutasteride; tamsulosin hydrochloride - capsules - dutasteride 0.5 mg; tamsulosin hydrochloride 0.4 mg - tamsulosin - treatment of moderate to severe symptoms of benign prostatic hyperplasia (bph). reduction in the risk of acute urinary retention (aur) and surgery in patients with moderate to severe symptoms of bph.